Literature DB >> 12148091

Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus.

Colin D Veal1, Francesca Capon, Michael H Allen, Emma K Heath, Julie C Evans, Andrew Jones, Shanta Patel, David Burden, David Tillman, Jonathan N W N Barker, Richard C Trembath.   

Abstract

Psoriasis is a common skin disorder of multifactorial origin. Genomewide scans for disease susceptibility have repeatedly demonstrated the existence of a major locus, PSORS1 (psoriasis susceptibility 1), contained within the major histocompatibility complex (MHC), on chromosome 6p21. Subsequent refinement studies have highlighted linkage disequilibrium (LD) with psoriasis, along a 150-kb segment that includes at least three candidate genes (encoding human leukocyte antigen-C [HLA-C], alpha-helix-coiled-coil-rod homologue, and corneodesmosin), each of which has been shown to harbor disease-associated alleles. However, the boundaries of the minimal PSORS1 region remain poorly defined. Moreover, interpretations of allelic association with psoriasis are compounded by limited insight of LD conservation within MHC class I interval. To address these issues, we have pursued a high-resolution genetic characterization of the PSORS1 locus. We resequenced genomic segments along a 220-kb region at chromosome 6p21 and identified a total of 119 high-frequency SNPs. Using 59 SNPs (18 coding and 41 noncoding SNPs) whose position was representative of the overall marker distribution, we genotyped a data set of 171 independently ascertained parent-affected offspring trios. Family-based association analysis of this cohort highlighted two SNPs (n.7 and n.9) respectively lying 7 and 4 kb proximal to HLA-C. These markers generated highly significant evidence of disease association (P<10-9), several orders of magnitude greater than the observed significance displayed by any other SNP that has previously been associated with disease susceptibility. This observation was replicated in a Gujarati Indian case/control data set. Haplotype-based analysis detected overtransmission of a cluster of chromosomes, which probably originated by ancestral mutation of a common disease-bearing haplotype. The only markers exclusive to the overtransmitted chromosomes are SNPs n.7 and n.9, which define a 10-kb PSORS1 core risk haplotype. These data demonstrate the power of SNP haplotype-based association analyses and provide high-resolution dissection of genetic variation across the PSORS1 interval, the major susceptibility locus for psoriasis.

Entities:  

Mesh:

Year:  2002        PMID: 12148091      PMCID: PMC379192          DOI: 10.1086/342289

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  40 in total

1.  Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan.

Authors:  R P Nair; T Henseler; S Jenisch; P Stuart; C K Bichakjian; W Lenk; E Westphal; S W Guo; E Christophers; J J Voorhees; J T Elder
Journal:  Hum Mol Genet       Date:  1997-08       Impact factor: 6.150

2.  Amplification of human minisatellites by the polymerase chain reaction: towards DNA fingerprinting of single cells.

Authors:  A J Jeffreys; V Wilson; R Neumann; J Keyte
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

3.  Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis.

Authors:  R C Trembath; R L Clough; J L Rosbotham; A B Jones; R D Camp; A Frodsham; J Browne; R Barber; J Terwilliger; G M Lathrop; J N Barker
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

4.  HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics.

Authors:  E Mallon; M Bunce; F Wojnarowska; K Welsh
Journal:  J Invest Dermatol       Date:  1997-08       Impact factor: 8.551

5.  Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease.

Authors:  G J Nevitt; P E Hutchinson
Journal:  Br J Dermatol       Date:  1996-10       Impact factor: 9.302

6.  Study of aspartate at residue 9 of HLA-C molecules in Japanese patients with psoriasis vulgaris.

Authors:  A Asahina; S Kuwata; K Tokunaga; T Juji; H Nakagawa
Journal:  J Dermatol Sci       Date:  1996-11       Impact factor: 4.563

Review 7.  Of genes and antigens: the inheritance of psoriasis.

Authors:  J T Elder; T Henseler; E Christophers; J J Voorhees; R P Nair
Journal:  J Invest Dermatol       Date:  1994-11       Impact factor: 8.551

8.  Do specific pockets of HLA-C molecules predispose Jewish patients to psoriasis vulgaris?

Authors:  A Roitberg-Tambur; A Friedmann; E E Tzfoni; S Battat; R Ben Hammo; C Safirman; K Tokunaga; A Asahina; C Brautbar
Journal:  J Am Acad Dermatol       Date:  1994-12       Impact factor: 11.527

9.  The annual cost of psoriasis.

Authors:  H M Sander; L F Morris; C M Phillips; P E Harrison; A Menter
Journal:  J Am Acad Dermatol       Date:  1993-03       Impact factor: 11.527

10.  Psoriasis and HLA-Cw6.

Authors:  A Tiilikainen; A Lassus; J Karvonen; P Vartiainen; M Julin
Journal:  Br J Dermatol       Date:  1980-02       Impact factor: 9.302

View more
  45 in total

1.  The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs.

Authors: 
Journal:  Am J Hum Genet       Date:  2003-07-07       Impact factor: 11.025

2.  Entropy-based SNP selection for genetic association studies.

Authors:  Jochen Hampe; Stefan Schreiber; Michael Krawczak
Journal:  Hum Genet       Date:  2003-09-18       Impact factor: 4.132

3.  The linkage disequilibrium maps of three human chromosomes across four populations reflect their demographic history and a common underlying recombination pattern.

Authors:  Francisco M De La Vega; Hadar Isaac; Andrew Collins; Charles R Scafe; Bjarni V Halldórsson; Xiaoping Su; Ross A Lippert; Yu Wang; Marion Laig-Webster; Ryan T Koehler; Janet S Ziegle; Lewis T Wogan; Junko F Stevens; Kyle M Leinen; Sheri J Olson; Karl J Guegler; Xiaoqing You; Lily H Xu; Heinz G Hemken; Francis Kalush; Mitsuo Itakura; Yi Zheng; Guy de Thé; Stephen J O'Brien; Andrew G Clark; Sorin Istrail; Michael W Hunkapiller; Eugene G Spier; Dennis A Gilbert
Journal:  Genome Res       Date:  2005-03-21       Impact factor: 9.043

4.  Genetic association analysis using data from triads and unrelated subjects.

Authors:  Michael P Epstein; Colin D Veal; Richard C Trembath; Jonathan N W N Barker; Chun Li; Glen A Satten
Journal:  Am J Hum Genet       Date:  2005-02-14       Impact factor: 11.025

Review 5.  Factors affecting statistical power in the detection of genetic association.

Authors:  Derek Gordon; Stephen J Finch
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

6.  Combined haplotype relative risk (CHRR): a general and simple genetic association test that combines trios and unrelated case-controls.

Authors:  Chao-Yu Guo; Kathryn L Lunetta; Anita L DeStefano; L Adrienne Cupples
Journal:  Genet Epidemiol       Date:  2009-01       Impact factor: 2.135

7.  Sequence variation in IGF1R is associated with differences in insulin levels in nondiabetic Old Order Amish.

Authors:  Adam C Naj; Wen-Hong L Kao; Jeffrey R O'Connell; Braxton D Mitchell; Kristi D Silver
Journal:  Diabetes Metab Res Rev       Date:  2009-11       Impact factor: 4.876

Review 8.  Psoriasis: advances in pathophysiology and management.

Authors:  A MacDonald; A D Burden
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

Review 9.  Psoriasis: a complex clinical and genetic disorder.

Authors:  Helgi Valdimarsson; Ari Karason; Johann E Gudjonsson
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

Review 10.  New insights into the pathogenesis and genetics of psoriatic arthritis.

Authors:  Kristine E Nograles; Richard D Brasington; Anne M Bowcock
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.